NEWS

News Articles

Gilead ramps up production of experimental Covid-19 treatment amid criticism over access

April 5, 2020

In response to intensifying demand, Gilead Sciences (GILD) has been ramping up production of its experimental remdesivir treatment that is being tested to combat the novel coronavirus. The drug maker now has 1.5 million individual dosages that could be used for more than 140,000 patients and is supplying the medicine, which is being made available through clinical…

Read More

ExxonMobil to develop new industrial-style, reusable COVID-19 protection gear

April 3, 2020

ExxonMobil has partnered with the Global Center for Medical Innovation (GCMI) to redesign and manufacture COVID-19 reusable personal protection equipment for health care workers. ExxonMobil will leverage its experience in polymer-based technologies to develop face shields and masks which are in short supply. The energy firm will also supply raw materials required to manufacture the new industrial-style face…

Read More

Trump to expand use of Defense Production Act to build ventilators

April 2, 2020

President Trump announced Thursday that he is expanding his use of the Defense Production Act (DPA) to help several manufacturers secure supplies for ventilators. Trump issued a memorandum allowing the secretary of Health and Human Services to use authority under the powerful Korean War-era law to help six companies, including General Electric and Medtronic, secure supplies…

Read More

BARDA Simplified TechWatch Portal for medical countermeasure (MCM) R&D Proposals

April 2, 2020

 The Biomedical Advanced Research and Development Authority (BARDA) is a part of HHS under the Assistant Secretary of Preparedness and Response (ASPR). BARDA has developed a simplified portal for submission of proposals to support U.S. government medical countermeasure (MCM) research and development for products targeted to COVID-19. The TechWatch program can be found as part…

Read More

BD to launch point-of-care COVID-19 antibody test

April 2, 2020

Becton Dickinson (NYSE:BDX) yesterday announced a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19 in as little as 15 minutes. The new test, developed and manufactured by BioMedomics (Morrisville, N.C.), will be available through BD and distributed exclusively by Henry Schein (NSDQ:HSIC) to healthcare providers throughout the United States. The test…

Read More

COVID-19 vaccine clinical trial in Atlanta is full

April 2, 2020

The Atlanta clinical trial testing a vaccine for the prevention of COVID-19 is full. Seventeen participants have joined the Atlanta part of the clinical trial, which is overseen by Emory University’s Vaccine and Treatment Evaluation Unit (VTEU), a spokesperson said.  The vaccine developed by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna…

Read More